Pompe Disease Market 2027 By Therapy Type, Molecule Type, Route of Administration, Dosage Forms and Geography | The Insight Partners

Pompe Disease Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Therapy Type (Enzyme Replacement Therapy, Substrate Reduction Therapy); Molecule Type (Biologics, Small Molecules); Route of Administration (Oral, Parenteral); Dosage Forms (Solid, Liquid) and Geography

Report Code: TIPRE00015809 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Pompe disease is induced by an accumulation of glycogen in the lysosome due to the lysosomal acid alpha-glucosidase enzyme deficiency. It is an autosomal recessive metabolic disorder that damages muscle and nerve cells throughout the body. It is a genetic disorder. Three major types of Pompe disease named classic infantile, non-classic infantile, and late-onset appear at different life stages.

MARKET DYNAMICS

The Pompe Disease market is growing due to the rise in gene therapy and enzyme replacement therapies are contributing in the growth of market. However, the lack of awareness and expensive therapy treatment is expected to hamper the growth of the global Pompe Disease market.

MARKET SCOPE

The "Pompe Disease Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Pompe Disease market with detailed market segmentation therapy type, molecule type, route of administration, dosage forms and geography. The Pompe Disease market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Pompe Disease market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Pompe Disease market is segmented on the basis of therapy type, molecule type, route of administration and dosage forms. Based on therapy type, the market is segmented as Enzyme Replacement Therapy and Substrate Reduction Therapy. On the basis of molecule type, the market segmented into Biologics and Small Molecules. On the basis of Route of Administration the market is segmented into Oral and Parenteral. On the basis of dosage form the market is segmented into Solid and Liquid

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Pompe Disease market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pompe Disease market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Pompe Disease market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pompe Disease market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Pompe Disease market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Pompe Disease market are anticipated to have lucrative growth opportunities in the future with the rising demand for Pompe Disease in the global market. Below mentioned is the list of few companies engaged in the Pompe Disease market.

The report also includes the profiles of key players in Pompe Disease market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Amicus Therapeutics
  •  BioMarin Pharmaceutical
  •  Genzyme
  •  Audentes Therapeutics
  •  EpiVax
  •  Oxyrane
  •  Sangamo BioSciences
  •  Valerion Therapeutics
  •  Centogene
  •  Sanofi

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pompe Disease Market - By Therapy Type
1.3.2 Pompe Disease Market - By Molecule Type
1.3.3 Pompe Disease Market - By Route of Administration
1.3.4 Pompe Disease Market - By Dosage Forms
1.3.5 Pompe Disease Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. POMPE DISEASE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. POMPE DISEASE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. POMPE DISEASE MARKET - GLOBAL MARKET ANALYSIS
6.1. POMPE DISEASE - GLOBAL MARKET OVERVIEW
6.2. POMPE DISEASE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. POMPE DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY TYPE
7.1. OVERVIEW
7.2. THERAPY TYPE MARKET FORECASTS AND ANALYSIS
7.3. ENZYME REPLACEMENT THERAPY
7.3.1. Overview
7.3.2. Enzyme Replacement Therapy Market Forecast and Analysis
7.4. SUBSTRATE REDUCTION THERAPY
7.4.1. Overview
7.4.2. Substrate Reduction Therapy Market Forecast and Analysis
8. POMPE DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - MOLECULE TYPE
8.1. OVERVIEW
8.2. MOLECULE TYPE MARKET FORECASTS AND ANALYSIS
8.3. BIOLOGICS
8.3.1. Overview
8.3.2. Biologics Market Forecast and Analysis
8.4. SMALL MOLECULES
8.4.1. Overview
8.4.2. Small Molecules Market Forecast and Analysis
9. POMPE DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. PARENTERAL
9.4.1. Overview
9.4.2. Parenteral Market Forecast and Analysis
10. POMPE DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORMS
10.1. OVERVIEW
10.2. DOSAGE FORMS MARKET FORECASTS AND ANALYSIS
10.3. SOLID
10.3.1. Overview
10.3.2. Solid Market Forecast and Analysis
10.4. LIQUID
10.4.1. Overview
10.4.2. Liquid Market Forecast and Analysis

11. POMPE DISEASE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Pompe Disease Market Overview
11.1.2 North America Pompe Disease Market Forecasts and Analysis
11.1.3 North America Pompe Disease Market Forecasts and Analysis - By Therapy Type
11.1.4 North America Pompe Disease Market Forecasts and Analysis - By Molecule Type
11.1.5 North America Pompe Disease Market Forecasts and Analysis - By Route of Administration
11.1.6 North America Pompe Disease Market Forecasts and Analysis - By Dosage Forms
11.1.7 North America Pompe Disease Market Forecasts and Analysis - By Countries
11.1.7.1 United States Pompe Disease Market
11.1.7.1.1 United States Pompe Disease Market by Therapy Type
11.1.7.1.2 United States Pompe Disease Market by Molecule Type
11.1.7.1.3 United States Pompe Disease Market by Route of Administration
11.1.7.1.4 United States Pompe Disease Market by Dosage Forms
11.1.7.2 Canada Pompe Disease Market
11.1.7.2.1 Canada Pompe Disease Market by Therapy Type
11.1.7.2.2 Canada Pompe Disease Market by Molecule Type
11.1.7.2.3 Canada Pompe Disease Market by Route of Administration
11.1.7.2.4 Canada Pompe Disease Market by Dosage Forms
11.1.7.3 Mexico Pompe Disease Market
11.1.7.3.1 Mexico Pompe Disease Market by Therapy Type
11.1.7.3.2 Mexico Pompe Disease Market by Molecule Type
11.1.7.3.3 Mexico Pompe Disease Market by Route of Administration
11.1.7.3.4 Mexico Pompe Disease Market by Dosage Forms
11.2. EUROPE
11.2.1 Europe Pompe Disease Market Overview
11.2.2 Europe Pompe Disease Market Forecasts and Analysis
11.2.3 Europe Pompe Disease Market Forecasts and Analysis - By Therapy Type
11.2.4 Europe Pompe Disease Market Forecasts and Analysis - By Molecule Type
11.2.5 Europe Pompe Disease Market Forecasts and Analysis - By Route of Administration
11.2.6 Europe Pompe Disease Market Forecasts and Analysis - By Dosage Forms
11.2.7 Europe Pompe Disease Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Pompe Disease Market
11.2.7.1.1 Germany Pompe Disease Market by Therapy Type
11.2.7.1.2 Germany Pompe Disease Market by Molecule Type
11.2.7.1.3 Germany Pompe Disease Market by Route of Administration
11.2.7.1.4 Germany Pompe Disease Market by Dosage Forms
11.2.7.2 France Pompe Disease Market
11.2.7.2.1 France Pompe Disease Market by Therapy Type
11.2.7.2.2 France Pompe Disease Market by Molecule Type
11.2.7.2.3 France Pompe Disease Market by Route of Administration
11.2.7.2.4 France Pompe Disease Market by Dosage Forms
11.2.7.3 Italy Pompe Disease Market
11.2.7.3.1 Italy Pompe Disease Market by Therapy Type
11.2.7.3.2 Italy Pompe Disease Market by Molecule Type
11.2.7.3.3 Italy Pompe Disease Market by Route of Administration
11.2.7.3.4 Italy Pompe Disease Market by Dosage Forms
11.2.7.4 Spain Pompe Disease Market
11.2.7.4.1 Spain Pompe Disease Market by Therapy Type
11.2.7.4.2 Spain Pompe Disease Market by Molecule Type
11.2.7.4.3 Spain Pompe Disease Market by Route of Administration
11.2.7.4.4 Spain Pompe Disease Market by Dosage Forms
11.2.7.5 United Kingdom Pompe Disease Market
11.2.7.5.1 United Kingdom Pompe Disease Market by Therapy Type
11.2.7.5.2 United Kingdom Pompe Disease Market by Molecule Type
11.2.7.5.3 United Kingdom Pompe Disease Market by Route of Administration
11.2.7.5.4 United Kingdom Pompe Disease Market by Dosage Forms
11.2.7.6 Rest of Europe Pompe Disease Market
11.2.7.6.1 Rest of Europe Pompe Disease Market by Therapy Type
11.2.7.6.2 Rest of Europe Pompe Disease Market by Molecule Type
11.2.7.6.3 Rest of Europe Pompe Disease Market by Route of Administration
11.2.7.6.4 Rest of Europe Pompe Disease Market by Dosage Forms
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Pompe Disease Market Overview
11.3.2 Asia-Pacific Pompe Disease Market Forecasts and Analysis
11.3.3 Asia-Pacific Pompe Disease Market Forecasts and Analysis - By Therapy Type
11.3.4 Asia-Pacific Pompe Disease Market Forecasts and Analysis - By Molecule Type
11.3.5 Asia-Pacific Pompe Disease Market Forecasts and Analysis - By Route of Administration
11.3.6 Asia-Pacific Pompe Disease Market Forecasts and Analysis - By Dosage Forms
11.3.7 Asia-Pacific Pompe Disease Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Pompe Disease Market
11.3.7.1.1 Australia Pompe Disease Market by Therapy Type
11.3.7.1.2 Australia Pompe Disease Market by Molecule Type
11.3.7.1.3 Australia Pompe Disease Market by Route of Administration
11.3.7.1.4 Australia Pompe Disease Market by Dosage Forms
11.3.7.2 China Pompe Disease Market
11.3.7.2.1 China Pompe Disease Market by Therapy Type
11.3.7.2.2 China Pompe Disease Market by Molecule Type
11.3.7.2.3 China Pompe Disease Market by Route of Administration
11.3.7.2.4 China Pompe Disease Market by Dosage Forms
11.3.7.3 India Pompe Disease Market
11.3.7.3.1 India Pompe Disease Market by Therapy Type
11.3.7.3.2 India Pompe Disease Market by Molecule Type
11.3.7.3.3 India Pompe Disease Market by Route of Administration
11.3.7.3.4 India Pompe Disease Market by Dosage Forms
11.3.7.4 Japan Pompe Disease Market
11.3.7.4.1 Japan Pompe Disease Market by Therapy Type
11.3.7.4.2 Japan Pompe Disease Market by Molecule Type
11.3.7.4.3 Japan Pompe Disease Market by Route of Administration
11.3.7.4.4 Japan Pompe Disease Market by Dosage Forms
11.3.7.5 South Korea Pompe Disease Market
11.3.7.5.1 South Korea Pompe Disease Market by Therapy Type
11.3.7.5.2 South Korea Pompe Disease Market by Molecule Type
11.3.7.5.3 South Korea Pompe Disease Market by Route of Administration
11.3.7.5.4 South Korea Pompe Disease Market by Dosage Forms
11.3.7.6 Rest of Asia-Pacific Pompe Disease Market
11.3.7.6.1 Rest of Asia-Pacific Pompe Disease Market by Therapy Type
11.3.7.6.2 Rest of Asia-Pacific Pompe Disease Market by Molecule Type
11.3.7.6.3 Rest of Asia-Pacific Pompe Disease Market by Route of Administration
11.3.7.6.4 Rest of Asia-Pacific Pompe Disease Market by Dosage Forms
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Pompe Disease Market Overview
11.4.2 Middle East and Africa Pompe Disease Market Forecasts and Analysis
11.4.3 Middle East and Africa Pompe Disease Market Forecasts and Analysis - By Therapy Type
11.4.4 Middle East and Africa Pompe Disease Market Forecasts and Analysis - By Molecule Type
11.4.5 Middle East and Africa Pompe Disease Market Forecasts and Analysis - By Route of Administration
11.4.6 Middle East and Africa Pompe Disease Market Forecasts and Analysis - By Dosage Forms
11.4.7 Middle East and Africa Pompe Disease Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Pompe Disease Market
11.4.7.1.1 South Africa Pompe Disease Market by Therapy Type
11.4.7.1.2 South Africa Pompe Disease Market by Molecule Type
11.4.7.1.3 South Africa Pompe Disease Market by Route of Administration
11.4.7.1.4 South Africa Pompe Disease Market by Dosage Forms
11.4.7.2 Saudi Arabia Pompe Disease Market
11.4.7.2.1 Saudi Arabia Pompe Disease Market by Therapy Type
11.4.7.2.2 Saudi Arabia Pompe Disease Market by Molecule Type
11.4.7.2.3 Saudi Arabia Pompe Disease Market by Route of Administration
11.4.7.2.4 Saudi Arabia Pompe Disease Market by Dosage Forms
11.4.7.3 U.A.E Pompe Disease Market
11.4.7.3.1 U.A.E Pompe Disease Market by Therapy Type
11.4.7.3.2 U.A.E Pompe Disease Market by Molecule Type
11.4.7.3.3 U.A.E Pompe Disease Market by Route of Administration
11.4.7.3.4 U.A.E Pompe Disease Market by Dosage Forms
11.4.7.4 Rest of Middle East and Africa Pompe Disease Market
11.4.7.4.1 Rest of Middle East and Africa Pompe Disease Market by Therapy Type
11.4.7.4.2 Rest of Middle East and Africa Pompe Disease Market by Molecule Type
11.4.7.4.3 Rest of Middle East and Africa Pompe Disease Market by Route of Administration
11.4.7.4.4 Rest of Middle East and Africa Pompe Disease Market by Dosage Forms
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Pompe Disease Market Overview
11.5.2 South and Central America Pompe Disease Market Forecasts and Analysis
11.5.3 South and Central America Pompe Disease Market Forecasts and Analysis - By Therapy Type
11.5.4 South and Central America Pompe Disease Market Forecasts and Analysis - By Molecule Type
11.5.5 South and Central America Pompe Disease Market Forecasts and Analysis - By Route of Administration
11.5.6 South and Central America Pompe Disease Market Forecasts and Analysis - By Dosage Forms
11.5.7 South and Central America Pompe Disease Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Pompe Disease Market
11.5.7.1.1 Brazil Pompe Disease Market by Therapy Type
11.5.7.1.2 Brazil Pompe Disease Market by Molecule Type
11.5.7.1.3 Brazil Pompe Disease Market by Route of Administration
11.5.7.1.4 Brazil Pompe Disease Market by Dosage Forms
11.5.7.2 Argentina Pompe Disease Market
11.5.7.2.1 Argentina Pompe Disease Market by Therapy Type
11.5.7.2.2 Argentina Pompe Disease Market by Molecule Type
11.5.7.2.3 Argentina Pompe Disease Market by Route of Administration
11.5.7.2.4 Argentina Pompe Disease Market by Dosage Forms
11.5.7.3 Rest of South and Central America Pompe Disease Market
11.5.7.3.1 Rest of South and Central America Pompe Disease Market by Therapy Type
11.5.7.3.2 Rest of South and Central America Pompe Disease Market by Molecule Type
11.5.7.3.3 Rest of South and Central America Pompe Disease Market by Route of Administration
11.5.7.3.4 Rest of South and Central America Pompe Disease Market by Dosage Forms

12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. POMPE DISEASE MARKET, KEY COMPANY PROFILES
13.1. AMICUS THERAPEUTICS
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BIOMARIN PHARMACEUTICAL
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. GENZYME
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. AUDENTES THERAPEUTICS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. EPIVAX
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. OXYRANE
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. SANGAMO BIOSCIENCES
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. VALERION THERAPEUTICS
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CENTOGENE
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SANOFI
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Amicus Therapeutics
2. BioMarin Pharmaceutical
3. Genzyme
4. Audentes Therapeutics
5. EpiVax
6. Oxyrane
7. Sangamo BioSciences
8. Valerion Therapeutics
9. Centogene
10. Sanofi
TIPRE00015809
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking